Clinical & Regulatory
Palatin Technologies Inc.
Palatin Technologies Inc. announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD).
Microsulis Medical Limited
Microsulis Medical Limited announced that the FDA has provided the company 510(k) clearance to market the Acculis Accu2i percutaneous microwave tissue ablation, or pMTA, system for the coagulation of soft tissue during surgical procedures.
Biosensors International Group, Limited
Biosensors International Group, Limited announced that it had received approval for its BioMatrixTM drug-eluting stent system from the Department of Health in Taiwan.
Cardiac Dimensions, Inc.
Cardiac Dimensions, Inc. announced that the 12-month follow-up results from the TITAN(TM) trial of the company's CARILLON(R) Mitral Contour System will be presented at the European Society of Cardiology 2010 Congress on August 29, 2010 in Stockholm.
Endologix
Endologix announced that it has received U.S. Food and Drug Administration (FDA) approval for its new PowerFit Aortic Extensions.
InspireMD Introduces New And Improved Delivery System For MGuard Coronary Stent System
InspireMD Ltd. has introduced a new and improved delivery system for its MGuard coronary stent system.
Onset Receives FDA 510(k) Clearance For Additional Size Applications For SoloPath Endovascular Access Catheter
Onset Medical Corporation (Onset) has received FDA 510(k) marketing clearance for new access applications of the company's SoloPath transfemoral endovascular access catheter.
Cardiome Pharma Corp. Drug Announcement
Cardiome Pharma Corp. announced that the development of its key drug to treat irregular heart beats will be delayed.
Ventracor Limited Announce Results Of US Feasibility Trial Of The VentraAssist LVAD
Ventracor Limited released the clinical results of the US Feasibility Trial at the annual meeting of the International Society of Heart and Lung Transplantation (ISHLT) in Boston of its VentrAssist Left Ventricular Assist Device (LVAD).
TomTec Introduces New Version Of Its 2D Cardiac Performance Analysis Software
TomTec Imaging Systems GmbH (TomTec) has launched the latest version of its 2D Cardiac Performance Analysis (2D CPA) package as part of TomTec's Image-Arena multimodality imaging solution.
